IBDP CAS Sample log IBDP CAS Coordinator Gyanendra Tewatia, India
Cas clinique: double Jeopardy - mao-monaco.org€¦ · PAR CANCER DU SEIN DOUBLE DANS LE BRAS SANS...
Transcript of Cas clinique: double Jeopardy - mao-monaco.org€¦ · PAR CANCER DU SEIN DOUBLE DANS LE BRAS SANS...
7
JOHN NAISHPUBLISHED: 00:30 GMT, 7 April 2012 |
UPDATED: 02:23 GMT, 7 April 2012Read more:
http://www.dailymail.co.uk/health/article-2126379/
Sentenced to death for being old:
The NHS denies life-saving treatment to the elderly,
as one man's chilling story reveals
Post-operative Radiotherapy In Minimum-risk Elderly – PRIME II
Kunkler IH, Williams LJ, Jack W, Canney P, Prescott RJ, Dixon JM on behalf of the
PRIME II investigators
San Antonio Breast Cancer Symposium, Dec 10-14th, 2013
Local control
Local recurrence
5 yr actuarial rate
No RT (n=668)
26 4.1%
RT (n=658)
6 1.3%
Total 32
San Antonio Breast Cancer Symposium - Cancer Therapy and Research Center at UT Health Science Center – December 10-14, 2013
Overall survival
Overall survival (deaths)
5 yr actuarial rate
No RT (n=668)
49 93.8%
RT (n=658)
38 94.2%
Total 87
San Antonio Breast Cancer Symposium - Cancer Therapy and Research Center at UT Health Science Center – December 10-14, 2013
Overall survival
Overall survival (deaths)
5 yr actuarial rate
No RT (n=668)
49 93.8%
RT (n=658)
38 94.2%
Total 87
San Antonio Breast Cancer Symposium - Cancer Therapy and Research Center at UT Health Science Center – December 10-14, 2013
MAIS LE NOMBRE DE
DECES
PAR CANCER DU SEIN
DOUBLE
DANS LE BRAS SANS RT
THE LANCET ONCOLOGY Volume 16, No. 3, p266–273, March 2015
• However, the 5-year rate of ipsilateral
breast tumour recurrence is probably low
enough for omission of radiotherapy to be
considered for some patients.
12
13
MESSAGE
La radiothérapie reste un standard,
mais
selon la biologie du cancer
son application et son étendue
peuvent se discuter…
15
Erreurs
dans le cas de Jeanne-Marie…
• Qui a demandé son opinion?
• Pourquoi n’y a-t-il pas un
diagnostic précis de son cancer?
• Pourquoi n’a-t-on pas discuté des
options de traitement?